149 related articles for article (PubMed ID: 37642049)
1. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
Dhani FK; Daryanto B; Seputra KP
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
[TBL] [Abstract][Full Text] [Related]
2. Pelvic radiotherapy in patients with hydronephrosis in stage IIIB cancer of the cervix: renal effects and the optimal timing for urinary diversion?
Horan G; McArdle O; Martin J; Collins CD; Faul C
Gynecol Oncol; 2006 Jun; 101(3):441-4. PubMed ID: 16337996
[TBL] [Abstract][Full Text] [Related]
3. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
[TBL] [Abstract][Full Text] [Related]
4. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort.
Lapitan MC; Buckley BS
J Obstet Gynaecol Res; 2011 Aug; 37(8):1061-70. PubMed ID: 21481096
[TBL] [Abstract][Full Text] [Related]
5. Effect of hydronephrosis on survival in advanced stage cervical cancer.
Goklu MR; Seckin KD; Togrul C; Goklu Y; Tahaoglu AE; Oz M; Ertas IE
Asian Pac J Cancer Prev; 2015; 16(10):4219-22. PubMed ID: 26028076
[TBL] [Abstract][Full Text] [Related]
6. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival.
Patel K; Foster NR; Kumar A; Grudem M; Longenbach S; Bakkum-Gamez J; Haddock M; Dowdy S; Jatoi A
Support Care Cancer; 2015 May; 23(5):1303-9. PubMed ID: 25339620
[TBL] [Abstract][Full Text] [Related]
7. Hydronephrosis in patients with cervical cancer: An improved stent-change therapy for ureteral obstruction Stent-change for ureteral obstruction in cervical cancer.
Li J; Cao H; Peng K; Chen R; Sun X
Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():49-53. PubMed ID: 36773470
[TBL] [Abstract][Full Text] [Related]
8. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2010 May; 117(2):270-5. PubMed ID: 20181381
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of ureteral obstruction in primary cervical cancer.
Lee SK; Jones HW
Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of hydronephrosis in the treatment of patients with locally advanced cervical cancer: a retrospective cohort.
Nóbrega L; Zanon JR; Andrade CEEMDC; Schmidt RL; Dos Santos MH; Dos Reis R
Int J Gynecol Cancer; 2022 Aug; 32(9):1123-8. PubMed ID: 35973739
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial.
Mokhmalji H; Braun PM; Martinez Portillo FJ; Siegsmund M; Alken P; Köhrmann KU
J Urol; 2001 Apr; 165(4):1088-92. PubMed ID: 11257644
[TBL] [Abstract][Full Text] [Related]
12. The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer.
Chao KS; Leung WM; Grigsby PW; Mutch DG; Herzog T; Perez CA
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1095-100. PubMed ID: 9539564
[TBL] [Abstract][Full Text] [Related]
13. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous nephrostomy in patients with advanced or recurrent cervical cancer.
Gadducci A; Madrigali A; Facchini V; Fioretti P
Clin Exp Obstet Gynecol; 1994; 21(2):71-3. PubMed ID: 8070118
[TBL] [Abstract][Full Text] [Related]
15. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
Kraemer PC; Borre M
Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
[TBL] [Abstract][Full Text] [Related]
16. Manifestation, latency and management of late urological complications after curative radiotherapy for cervical carcinoma.
Gellrich J; Hakenberg OW; Oehlschläger S; Wirth MP
Onkologie; 2003 Aug; 26(4):334-40. PubMed ID: 12972698
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome and management of ureteral obstruction secondary to gastric cancer.
Migita K; Watanabe A; Samma S; Ohyama T; Ishikawa H; Kagebayashi Y
World J Surg; 2011 May; 35(5):1035-41. PubMed ID: 21387134
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.
de Sousa Morais N; Pereira JP; Mota P; Carvalho-Dias E; Torres JN; Lima E
Urolithiasis; 2019 Dec; 47(6):567-573. PubMed ID: 30219938
[TBL] [Abstract][Full Text] [Related]
19. Outcome of palliative urinary diversion in the treatment of advanced malignancies.
Shekarriz B; Shekarriz H; Upadhyay J; Banerjee M; Becker H; Pontes JE; Wood DP
Cancer; 1999 Feb; 85(4):998-1003. PubMed ID: 10091780
[TBL] [Abstract][Full Text] [Related]
20. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]